Rosetta Inpharmatics Co-Founder Lee Hartwell Wins Nobel Prize | GenomeWeb

Lee Hartwell, director of the Fred Hutchinson Cancer Research Center in Seattle and co-developer of a key technology behind the founding of Rosetta Inpharmatics, was among three winners of this year’s Nobel Prize in Physiology or Medicine.

Hartwell, along with Paul Nurse and Timothy Hunt of the Imperial Cancer Research Fund in London, were recognized for their discoveries of molecular mechanisms that regulate the cell cycle.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Ivanka Trump and Secretary of Education Betsy DeVos call on girls to pursue STEM careers, the Associated Press reports.

Some science companies will be taking part in next month's March for Science, Fortune reports.

In Genome Research this week: longitudinal study of Burkholderia cenocepacia isolates from cystic fibrosis patients, long-read assembly approach, and more.

Shale oil companies are turning to DNA sequencing to find spots to drill, Reuters reports.